• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体和Fc融合蛋白的超滤行为:物理性质的影响

Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.

作者信息

Baek Youngbin, Singh Nripen, Arunkumar Abhiram, Borys Michael, Li Zheng J, Zydney Andrew L

机构信息

Department of Chemical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802.

Bristol-Myers Squibb, Global Manufacturing and Supply, Devens, Massachusetts.

出版信息

Biotechnol Bioeng. 2017 Sep;114(9):2057-2065. doi: 10.1002/bit.26326. Epub 2017 May 18.

DOI:10.1002/bit.26326
PMID:28464237
Abstract

Ultrafiltration (UF) is used for the final concentration and formulation of essentially all antibody-based therapeutics including both monoclonal antibodies (mAbs) and Fc-fusion proteins. The objective of this study was to quantitatively compare the filtrate flux behavior for two highly purified mAbs and an Fc-fusion protein under identical flow and buffer conditions. Filtrate flux data were obtained using a Pellicon 3 tangential flow filtration cassette over a wide range of transmembrane pressures and bulk protein concentrations. Independent experimental measurements were performed to evaluate the protein osmotic pressure and solution viscosity. The maximum achievable protein concentration was directly correlated with the solution viscosity, which controls the pressure drop and extent of back-filtration in the cassette. The filtrate flux data were analyzed using a recently developed model that accounts for the effects of intermolecular interactions and transmembrane pressure gradients on the extent of concentration polarization. These results provide important insights into the factors controlling the filtrate flux during the UF of concentrated protein solutions and an effective framework for the design/analysis of UF processes for the formulation of antibody-based therapeutics. Biotechnol. Bioeng. 2017;114: 2057-2065. © 2017 Wiley Periodicals, Inc.

摘要

超滤(UF)用于基本上所有基于抗体的治疗药物的最终浓缩和制剂制备,包括单克隆抗体(mAb)和Fc融合蛋白。本研究的目的是在相同的流动和缓冲条件下,对两种高度纯化的单克隆抗体和一种Fc融合蛋白的滤液通量行为进行定量比较。使用Pellicon 3切向流过滤盒在广泛的跨膜压力和总蛋白浓度范围内获得滤液通量数据。进行独立的实验测量以评估蛋白质渗透压和溶液粘度。可达到的最大蛋白质浓度与溶液粘度直接相关,溶液粘度控制着过滤盒中的压降和反向过滤程度。使用最近开发的一个模型分析滤液通量数据,该模型考虑了分子间相互作用和跨膜压力梯度对浓差极化程度的影响。这些结果为浓缩蛋白质溶液超滤过程中控制滤液通量的因素提供了重要见解,并为基于抗体的治疗药物制剂的超滤过程设计/分析提供了一个有效的框架。《生物技术与生物工程》2017年;114:2057 - 2065。©2017威利期刊公司

相似文献

1
Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.单克隆抗体和Fc融合蛋白的超滤行为:物理性质的影响
Biotechnol Bioeng. 2017 Sep;114(9):2057-2065. doi: 10.1002/bit.26326. Epub 2017 May 18.
2
Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions.高浓度抗体溶液的超滤:模块和缓冲条件影响的实验与建模
Biotechnol Prog. 2016 May;32(3):692-701. doi: 10.1002/btpr.2252. Epub 2016 May 17.
3
Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.用于对高浓度单克隆抗体制剂进行排名的多标准可制造性指标。
Biotechnol Bioeng. 2017 Sep;114(9):2043-2056. doi: 10.1002/bit.26329. Epub 2017 May 26.
4
Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.高浓度药物物质制造促进皮下给药的策略:综述。
Biotechnol Bioeng. 2020 Nov;117(11):3591-3606. doi: 10.1002/bit.27510. Epub 2020 Aug 3.
5
High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits.高浓度生物治疗制剂与超滤:第1部分压力限制
Biotechnol Prog. 2017 Jan;33(1):113-124. doi: 10.1002/btpr.2334. Epub 2016 Oct 15.
6
Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins.高浓度重组治疗蛋白制剂中的分子间相互作用。
Curr Opin Biotechnol. 2018 Oct;53:59-64. doi: 10.1016/j.copbio.2017.12.016. Epub 2017 Dec 23.
7
Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.分子间相互作用与高浓度单克隆抗体溶液的黏度
Pharm Res. 2015 Sep;32(9):3102-9. doi: 10.1007/s11095-015-1690-6. Epub 2015 Apr 2.
8
A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.超滤/错流过滤过程开发中预测唐南和体积排除效应的小规模方法。
J Pharm Sci. 2018 May;107(5):1296-1303. doi: 10.1016/j.xphs.2018.01.010. Epub 2018 Jan 12.
9
High-efficiency affinity precipitation of multiple industrial mAbs and Fc-fusion proteins from cell culture harvests using Z-ELP-E2 nanocages.使用 Z-ELP-E2 纳米笼从细胞培养收获物中高效亲和沉淀多种工业单克隆抗体和 Fc 融合蛋白。
Biotechnol Bioeng. 2018 Aug;115(8):2039-2047. doi: 10.1002/bit.26717. Epub 2018 May 9.
10
Effects of Impurities from Sugar Excipient on Filtrate Flux during Ultrafiltration and Diafiltration Process.糖辅料中的杂质对超滤和渗滤过程中滤液通量的影响
Membranes (Basel). 2021 Oct 11;11(10):775. doi: 10.3390/membranes11100775.

引用本文的文献

1
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeutics.高浓度生物治疗药物粘度降低的机理和预测配方开发。
MAbs. 2025 Dec;17(1):2550757. doi: 10.1080/19420862.2025.2550757. Epub 2025 Sep 15.
2
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
3
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties.
拓展具有类药性理化性质的抗体的发现和筛选的常规工具包的方法。
MAbs. 2023 Jan-Dec;15(1):2164459. doi: 10.1080/19420862.2022.2164459.
4
White paper on high-throughput process development for integrated continuous biomanufacturing.高通量工艺开发白皮书:用于集成连续生物制造
Biotechnol Bioeng. 2021 Sep;118(9):3275-3286. doi: 10.1002/bit.27757. Epub 2021 Apr 2.
5
Structure, heterogeneity and developability assessment of therapeutic antibodies.治疗性抗体的结构、异质性和可开发性评估。
MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17.